The FDA granted clearance for the BioFire Spotfire Respiratory Panel. It became the first respiratory panel to test for SARS-CoV-2 that also received a CLIA waiver. buff.ly/3x6tJ0e BioFire Diagnostics (now bioMérieux) U.S. FDA